The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.
Discover how Madison Burgess, a Michigan native, transformed her weight loss journey with Ozempic and micro-dosing techniques ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results